SBC Medical Group Holdings Incorporated Price & Performance (SBC)

SBC Medical Group is set to announce its full-year 2024 financial results on March 28, 2025, ahead of the U.S. market opening. A corresponding conference call will be held at 8:00 AM Eastern Time, offering insights into the company's performance and future outlook.1

SBC Medical Group's stock recently reached a 52-week low of $4.41, marking a significant decline from its peak of $36.52. Despite this downturn, the company maintains strong financial fundamentals, including a current ratio of 2.79 and more cash than debt, providing some stability amid industry pressures.2

SBC Medical Group's return on equity (ROE) stands at 26%, significantly above the healthcare industry average of 11%. This highlights the company's ability to generate profit relative to its equity capital, positioning it as a strong performer in its sector.3